FDA approves Wezlana for multiple inflammatory diseases
FDA approves Wezlana for multiple inflammatory diseasesby Lori SolomonThe U.S. Food and Drug Administration has approved Amgen's Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable w
Updated on: January 24,2024
18
FDA approves Wezlana for multiple inflammatory diseases
FDA approves Wezlana for multiple inflammatory diseasesby Lori SolomonThe U.S. Food and Drug Administration has approved Amgen's Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable w
Updated on:January 24,2024
18
